GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Rite Aid Corporation (RAD) [hlAlert]

Rating:
Outperform
RAD
up 259.82 %

Rite Aid Corporation (RAD) rated Outperform by Raymond James

Posted on: Friday,  Apr 12, 2013  8:25 AM ET by Raymond James

Raymond James rated Outperform Rite Aid Corporation (NYSE: RAD) on 04/12/2013, when the stock price was $2.29. Since
then, Rite Aid Corporation has gained 259.83% as of 11/13/2015's recent price of $8.24.
If you would have followed this Raymond James's recommendation on RAD, you would have gained 259.82% of your investment in 945 days.

Rite Aid Corporation is a retail drugstore chain in the United States serving customers in numerous states across the country and in the District of Columbia. It operates stores in the majority of the major U.S. metropolitan markets. The company operates in two business segments: the retail drug segment and the pharmacy benefit management segment.

Our equity research team has gained national attention for stock-picking ability and analyst performance, with recognition in leading publications such as the Wall Street Journal and Institutional Investor magazine*. Raymond James’ equity research philosophy focuses on a fundamental approach that encompasses three basic points. First, we believe that superior research on select companies within well-defined industries is preferable to broad general coverage. Second, we concentrate on the identification of quality companies demonstrating solid growth potential, with the goal of helping our clients maximize their investment returns. Third, to help our clients take advantage of pockets of inefficiency in the market, we strive to locate superior companies from across the country that have the potential to provide our clients with unique opportunities.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/12/2013 8:25 AM Buy
None
2.29
as of 12/13/2013
1 Week down  -3.30 %
1 Month up  5.70 %
3 Months up  55.30 %
1 YTD up  142.79 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy